Medical University of Vienna
Vienna, Austria
NCT Number: NCT03864757
The objective of this study is to evaluate pre- and intraoperative voice quality, the degree of vocal fold closure and the Maximum Phonation Time (MPT), first determined after temporary APrevent® VOIS implantation and then after permanent existing product implantation.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Vienna, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Short-term implantation of thyroplasty implant, VOIS, and evaluation of voice quality and glottal closure. After evaluation, remove VOIS and perform medialization of vocal folds using conventional thyroplasty.
Time frame: pre-surgery, right after temporarily implantation
Roughness(R), Breathiness(B), Hoarseness(H) Scale will be rated on a 4-point severity scale (0, normal; 1, mild deviance; 2, moderate deviance; and 3, severe deviance).
Time frame: pre-surgery, right after temporarily implantation
Time frame: pre-surgery, right after temporarily implantation
The prolongation of a/a:/, for as long as possible after maximal inspiration, and at a spontaneous, comfortable pitch and loudness.
Time frame: right after temporarily implantation
Visual analogue scale(VAS) of Subjective Surgeon Satisfaction will be rated from 0 to 10. (0= not satisfied, 10= very satisfied)
APrevent Biotech GmbH
Industry
APrevent Vocal Implant System (VOIS) for Adjustable Treatment of Unilateral Vocal Fold Paralysis (UVFP) - an Open-label, Non-randomized Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02163772
Cranial Nerve Diseases, Laryngeal Diseases
Taoyuan County, Taiwan
View Trial DetailsNCT05119842
Cranial Nerve Diseases, Laryngeal Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT00213837
Cranial Nerve Diseases, Laryngeal Diseases
Strasbourg, France
View Trial DetailsNCT05963165
Cranial Nerve Diseases, Laryngeal Diseases
Roma, Italy
View Trial Details